Please login to the form below

Not currently logged in
Email:
Password:

Icon appoints Dr Neil McCullough to senior compliance role

He joins the clinical research organisation from PPD

Icon Dr Neil McCulloughClinical research organisation (CRO) Icon has appointed Dr Neil McCullough as executive vice president of quality and compliance and corporate training.

Dr McCullough moved to the company from fellow CRO PPD, where he led the global quality and compliance division.

Prior to his time with PPD Dr McCullough spent nine years at Pfizer as a member of the Pfizer Global Medical Quality Assurance leadership team, and before that he served as a quality consultant to GlaxoSmithKline's division of manufacturing.

In total Dr McCullough brings to Icon over 22 years of experience leading global quality functions for pharmaceutical companies and CROs.  

Icon CEO Ciaran Murray said: “I would like to welcome Neil to ICON's executive leadership team. Delivering quality data and services to the standards required by clients and that are fully compliant with the evolving requirements of regulatory authorities underpins everything we do.  

“Neil's leadership and industry expertise will allow us to further enhance the quality and compliance solutions we offer to clients in support of their global drug development programmes.”  

In his new role Dr McCullough will provide strategic direction for quality management, quality assurance and corporate training across all Icon lines of business.

17th June 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics